Kevin O’Neill is President & CEO of GE UK in addition to his role as General Manager, Core Imaging, at GE Healthcare Life Sciences, based in Amersham, UK. Core Imaging is an integrated pharmaceutical business, that provides industry leading contrast agents, and nuclear medicine imaging agents that enable clinicians to perform essential imaging procedures, as well as providing molecular tools for therapy selection and treatment monitoring in patient care.
Prior to this, Kevin was the Chief Financial Officer of GE Healthcare Life Sciences, a $4.5 billion molecular medicine business that provides a broad range of industry-leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing.
Kevin has 20 years’ experience with GE, beginning in the Energy services business in the UK, and USA, followed by a series of finance roles in GE Healthcare. These included CFO Life Sciences Supply Chain, CFO, GE Healthcare, Western Europe, and CFO, Medical Diagnostics. He was appointed to his Core Imaging role in 2017 and became UK President & CEO in early 2018.
Prior to joining GE, Kevin was Financial Controller for Eurostar, the European high-speed train operator. He earned his MBA from City University, London in 1999, and is a Fellow of the Chartered Institute of Management Accountants.